LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
LIFR 抑制可增强 HDAC 抑制剂对三阴性乳腺癌的治疗效果
期刊:Communications Biology
影响因子:5.2
doi:10.1038/s42003-021-02741-7
Mengxing Li #, Suryavathi Viswanadhapalli #, Bindu Santhamma, Uday P Pratap, Yiliao Luo, Junhao Liu, Kristin A Altwegg, Weiwei Tang, Zexuan Liu, Xiaonan Li, Behnam Ebrahimi, Hui Yan, Yi Zou, Swapna Konda, Gangadhara R Sareddy, Zhenming Xu, Yidong Chen, Manjeet K Rao, Andrew J Brenner, Virginia G Kak